VP, Account Director - Purplemoon
IQVIA
Summary
Purplemoon, an IQVIA business, is a full-service, rare disease agency. We are currently seeking an experienced VP, Account Director who thrives at the intersection of strategy, relationships, and execution. You will oversee a high-profile, cross-functional team driving an exciting rare disease launch in the U.S. for a client with whom we share a well-established, trusted partnership. The ideal candidate will bring significant market access experience, with a strong understanding of the access and reimbursement dynamics that influence successful pharmaceutical launches.
Job description
Primary Responsibilities
- Serve as the senior strategic and operational lead across a major rare disease brand launch
- Build and nurture trusted client relationships through responsiveness, reliability, and forward-thinking counsel
- Bring market access expertise to strategic planning and execution, ensuring access, reimbursement, and commercialization considerations are reflected in the work
- Partner cross-functionally with creative, strategy, and program excellence to deliver best-in-class work
- Inspire and develop a growing account team, fostering curiosity, accountability, and professional growth
- Lead with an all-in mindset, balancing strategic vision with a willingness to roll up your sleeves
- Identify and drive opportunities for organic growth within the existing partnership
- Represent Purplemoon with confidence, clarity, and integrity in all client and internal interactions
Qualifications
- Bachelor's degree and/or equivalent combination of education and professional experience
- 7+ years of agency experience, with proven success leading complex, high-visibility healthcare accounts
- Market access experience is required, including a strong understanding of payer dynamics, reimbursement, and access-related commercialization strategies
- Experience in rare disease or specialty pharma strongly preferred
- Exceptional client leadership skills with a reputation for being hyper-responsive and solutions-oriented
- Strong people leadership abilities — a mentor who grows talent and builds cohesive, motivated teams
- Strategic mindset combined with operational precision and commercial awareness
- Collaborative spirit and a passion for doing meaningful, high-quality work
- Ability to travel as required for both client and IQVIA business needs
Requirements
- Bachelor's degree and/or equivalent combination of education and professional experience
- 7+ years of agency experience leading complex, high-visibility healthcare accounts
- Market access experience required, including payer dynamics, reimbursement, and access-related commercialization strategies
- Experience in rare disease or specialty pharma strongly preferred
- Exceptional client leadership skills
- Strong people leadership and mentorship abilities
- Strategic mindset with operational precision and commercial awareness
- Collaborative spirit
- Ability to travel as required
Benefits
- Health and welfare benefits
- Incentive plans
- Bonuses
Company overview
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Headquartered in Durham, North Carolina, the company operates in over 100 countries with approximately 86,000 employees worldwide. IQVIA specializes in creating intelligent connections across all aspects of healthcare through its proprietary IQVIA Connected Intelligence platform, which combines analytics, transformative technology, big data resources, and extensive domain expertise. The company's comprehensive portfolio includes clinical trial management, real-world evidence generation, commercial insights, and regulatory compliance services. IQVIA serves a diverse client base including pharmaceutical manufacturers, biotechnology companies, medical device firms, government agencies, and healthcare providers. With its Healthcare-grade AI capabilities and extensive global data assets, IQVIA accelerates the development and commercialization of innovative medical treatments while improving healthcare outcomes for patients globally. The company is publicly traded on the New York Stock Exchange under the ticker symbol IQV.